Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

C-Mer Eye Care Holdings Ltd

3309
Current price
2.05 HKD +0.03 HKD (+1.49%)
Last closed 2 HKD
ISIN KYG2R51A1053
Sector Healthcare
Industry Medical Care Facilities
Exchange Hong Kong Stock Exchange
Capitalization 2 863 760 514 HKD
Yield for 12 month -46.19 %
1Y
3Y
5Y
10Y
15Y
3309
21.11.2021 - 28.11.2021

C-MER Medical Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. The company operates through four segments: HK Medical Business, Sales of Medical Consumables, Mainland China Ophthalmic Business, and Mainland China Dental Business. It provides dental, oncology, medical aesthetics, and laboratory services; and engages in the sale of vision aid products, such as glasses and lens, and medical consumables. The company also operates eye and surgery centers, and satellite clinics that provide cataract, glaucoma, strabismus and refractive surgeries, external eye diseases, and vitreoretinal disease services. In addition, it provides dental and other medical services. The company was formerly known as C-MER Eye Care Holdings Limited and changed its name to C-MER Medical Holdings Limited in June 2024. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Medical Holdings Limited is a subsidiary of C-MER Group Limited. Address: Central Building, Central, Hong Kong

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

35.03 HKD

P/E ratio

45.8

Dividend Yield

Current Year

+1 926 136 523 HKD

Last Year

+1 733 858 647 HKD

Current Quarter

+951 336 028 HKD

Last Quarter

Current Year

+619 660 927 HKD

Last Year

+448 202 535 HKD

Current Quarter

+300 490 930 HKD

Last Quarter

Key Figures 3309

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 215 522 097 HKD
Operating Margin TTM 7.73 %
PE Ratio 45.8
Return On Assets TTM 3.17 %
PEG Ratio
Return On Equity TTM 4.88 %
Wall Street Target Price 35.03 HKD
Revenue TTM 1 898 343 156 HKD
Book Value 1.49 HKD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -2.9 %
Dividend Yield
Gross Profit TTM 358 632 507 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY 5.1 %
Profit Margin 3.32 %

Dividend Analytics 3309

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

-68 %

Dividend History 3309

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 31.05.2021
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 3309

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 45.8
Forward PE
Enterprise Value Revenue 1.45
Price Sales TTM 1.4493
Enterprise Value EBITDA 17.5574
Price Book MRQ 1.5566

Financials 3309

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 3309

For 52 weeks

1.81 HKD 3.86 HKD
50 Day MA 2.29 HKD
Shares Short Prior Month
200 Day MA 2.69 HKD
Short Ratio
Shares Short
Short Percent